AwardTape · Defense awards · Medical · Drugs and biologicals · FA442725C0003
FA442725C0003: $720K definitive contract to Boston Scientific Corp
Boston Scientific Corp holds a definitive contract from Department of the Air Force with $720K obligated since Oct 2023, against a ceiling of $4.0M. Latest action Dec 5, 2024.
Therasphere y90 treatments.
| PIID | FA442725C0003 |
|---|---|
| Type | definitive contract |
| Company | Boston Scientific Corp |
| Agency | Department of the Air Force |
| Contracting office | FA4427 60 CONS LGC |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $720K |
| Total obligated (lifetime) | $720K |
| Ceiling (base and all options) | $4.0M |
| Base date | Dec 5, 2024 |
| Latest action | Dec 5, 2024 |
| End date | Dec 5, 2029 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | CA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial